by creative | Jul 7, 2022 | News
(From left) UMediC Group Bhd (UMC) non-independent non-executive director Lau Chee Kheong and non-independent non-executive chairman Datuk Ng Chai Eng, Affin Hwang Investment Bank Bhd chairman and independent non-executive director Tunku Afwida Tunku A Malek, as well...
by creative | Jun 3, 2022 | News
UMEDIC GROUP BHD (UMC), which is seeking a listing on Bursa Malaysia, today signed an underwriting agreement with Affin Hwang Investment Bank Bhd (AHIBB), its principal adviser, sponsor, sole placement agent and sole underwriter. UMC’s initial public offering involves...
by creative | Jun 3, 2022 | News
UMediC Group Berhad has appointed Affin Hwang Investment Bank Berhad as its Principal Adviser, Sponsor, Sole Placement Agent, and Sole Underwriter for the group’s initial public offering on the ACE Market of Bursa Malaysia Securities. The group’s IPO will involve the...
by creative | Jun 3, 2022 | News
KUALA LUMPUR 3 Jun – UMediC Group Bhd. (UMC) menandatangani perjanjian taja jamin dengan Affin Hwang Investment Bank Bhd. (AHIBB) bagi tawaran awam permulaan (IPO) dan penyenaraiannya di Pasaran ACE Bursa Malaysia. AHIBB merupakan penasihat utama, penaja, ejen...
by creative | Jun 3, 2022 | News
林椿雄（左二）与莫娜苏莱雅（右二）签署IPO包销协议，并由黄才荣（左）和艾菲薇达（右）陪同。 （吉隆坡3日讯）医疗器械分销商UMediC集团，计划上市马股创业板，并与艾芬黄氏投行签署首次公开募股（IPO）的包销协议。 UMedic集团将在首次公开募股中，发行9722万4300新股；其中，艾芬黄氏将成为开放予大马公众和合格董事、员工和对公司有贡献的人士申购3178万2300股的独家承销商。 UMedic集团主要业务，是营销和分销各品牌的医疗器材；该集团还参与了医疗耗材的开发、制造和营销，并在市场立足了约20年之久。...
